Zobrazeno 1 - 10
of 20
pro vyhledávání: '"P E Penson"'
Publikováno v:
Exploratory Research in Clinical and Social Pharmacy, Vol 14, Iss , Pp 100454- (2024)
Background: An estimated 300 million people live with asthma globally. In England, a significant percentage live with poorly controlled asthma symptoms. Community pharmacists might be able to play a role in filling gaps in asthma care as they have th
Externí odkaz:
https://doaj.org/article/cf9a8d8aa547457d9df79ae4832faf8a
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Older care home residents are a vulnerable group of people with atrial fibrillation (AF) at high risk of adverse health events. The Atrial Fibrillation Better Care (ABC: Avoid stroke; Better symptom management; Cardiovascular and
Externí odkaz:
https://doaj.org/article/a6caaaec5e16431b9523f625d4a321e8
Autor:
Maciej Banach, Zeljko Reiner, Arrigo F.G. Cicero, Pierre Sabouret, Margus Viigimaa, Amirhossein Sahebkar, Arman Postadzhiyan, Dan Gaita, Daniel Pella, Peter E. Penson, International Lipid Expert Panel (ILEP)
Publikováno v:
Archives of Medical Science, Vol 18, Iss 6, Pp 1429-1434 (2022)
Externí odkaz:
https://doaj.org/article/934746987eb747bf8a5411b7d01e40c9
Autor:
Maciej Banach, Stanisław Surma, Zeljko Reiner, Niki Katsiki, Peter E. Penson, Zlatko Fras, Amirhossein Sahebkar, Francesco Paneni, Manfredi Rizzo, John Kastelein
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Dyslipidemia in patients with type 2 diabetes (DMT2) is one of the worst controlled worldwide, with only about 1/4 of patients being on the low-density lipoprotein cholesterol (LDL-C) target. There are many reasons of this, including physici
Externí odkaz:
https://doaj.org/article/464fdc478f9b4d84b59c7b59037f54e3
Autor:
Peter E. Penson, Eric Bruckert, David Marais, Željko Reiner, Matteo Pirro, Amirhossein Sahebkar, Gani Bajraktari, Erkin Mirrakhimov, Manfredi Rizzo, Dimitri P. Mikhailidis, Alexandros Sachinidis, Dan Gaita, Gustavs Latkovskis, Mohsen Mazidi, Peter P. Toth, Daniel Pella, Fahad Alnouri, Arman Postadzhiyan, Hung‐I Yeh, G.B. John Mancini, Stephan vonHaehling, Maciej Banach, International Lipid Expert Panel (ILEP)
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 13, Iss 3, Pp 1596-1622 (2022)
Abstract Statin intolerance is a clinical syndrome whereby adverse effects (AEs) associated with statin therapy [most commonly statin‐associated muscle symptoms (SAMS)] result in the discontinuation of therapy and consequently increase the risk of
Externí odkaz:
https://doaj.org/article/107164714e764cd5a677cc4278043acf
Autor:
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, Niki Katsiki, Dimitri P. Mikhailidis, Peter P. Toth, Ioanna Gouni-Berthold, John Mancini, David Marais, Patrick Moriarty, Massimiliano Ruscica, Amirhossein Sahebkar, Dragos Vinereanu, Arrigo Francesco Giuseppe Cicero, Maciej Banach, Julio Acosta, Mutaz Al-Khnifsawi, Fahad Alnouri, Fahma Amar, Atanas G. Atanasov, Gani Bajraktari, Sonu Bhaskar, Agata Bielecka-Dąbrowa, Bojko Bjelakovic, Eric Bruckert, Ibadete Bytyçi, Alberto Cafferata, Richard Ceska, Arrigo F.G. Cicero, Krzysztof Chlebus, Xavier Collet, Magdalena Daccord, Olivier Descamps, Dragan Djuric, Ronen Durst, Marat V. Ezhov, Zlatko Fras, Dan Gaita, Adrian V. Hernandez, Steven R. Jones, Jacek Jozwiak, Nona Kakauridze, Amani Kallel, Amit Khera, Karam Kostner, Raimondas Kubilius, Gustavs Latkovskis, G.B. John Mancini, A. David Marais, Seth S. Martin, Julio Acosta Martinez, Mohsen Mazidi, Erkin Mirrakhimov, Andre R. Miserez, Olena Mitchenko, Natalya P. Mitkovskaya, Patrick M. Moriarty, Seyed Mohammad Nabavi, Devaki Nair, Demosthenes B. Panagiotakos, György Paragh, Daniel Pella, Zaneta Petrulioniene, Matteo Pirro, Arman Postadzhiyan, Raman Puri, Ashraf Reda, Željko Reiner, Dina Radenkovic, Michał Rakowski, Jemaa Riadh, Dimitri Richter, Maria-Corina Serban, Abdullah M.A Shehab, Aleksandr B. Shek, Cesare R. Sirtori, Claudia Stefanutti, Tomasz Tomasik, Margus Viigimaa, Pedro Valdivielso, Branislav Vohnout, Stephan von Haehling, Michal Vrablik, Nathan D. Wong, Hung-I Yeh, Jiang Zhisheng, Andreas Zirlik
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106679- (2023)
Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around 10–25% of the general adult population, 15% of children, and even > 50% of individuals who have type 2 diabetes mellitus. It is a major cause of liver-related morbidit
Externí odkaz:
https://doaj.org/article/899e9c48cd3d4c8196a16bde19882118
Autor:
Maciej Banach, Alberico L. Catapano, Arrigo F.G. Cicero, Carlos Escobar, Bernhard Foger, Niki Katsiki, Gustavs Latkovskis, Michal Rakowski, Zeljko Reiner, Amirhossein Sahebkar, Geeta Sikand, Peter E. Penson, on behalf of the International Lipid Expert Panel (ILEP)
Publikováno v:
Pharmacological Research, Vol 183, Iss , Pp 106370- (2022)
The risk of atherosclerotic cardiovascular disease (ASCVD) is strongly related to lifetime exposure to low-density lipoprotein (LDL)-cholesterol in longitudinal studies. Lipid-lowering therapy (using statins, ezetimibe and PCSK9 inhibitors) substanti
Externí odkaz:
https://doaj.org/article/f51a4707860c413192f80b499263137c
Autor:
Paweł Krzemień, Sławomir Kasperczyk, Maciej Banach, Aleksandra Kasperczyk, Michał Dobrakowski, Tomasz Tomasik, Adam Windak, Mirosław Mastej, Alberico Catapano, Kausik K. Ray, Dimitri P. Mikhailidis, Peter P. Toth, George Howard, Gregory Y. H. Lip, Maciej Tomaszewski, Fadi J. Charchar, Naveed Sattar, Bryan Williams, Thomas M. MacDonald, Peter E. Penson, Jacek J. Jóźwiak
Publikováno v:
Archives of Medical Science, Vol 19, Iss 5, Pp 1214-1227 (2021)
Introduction Oxidative stress is one of many factors suspected to promote antinuclear autoantibody (ANA) formation. Reactive oxygen species can induce changes in the antigenic structure of macromolecules, causing the immune system to treat them as
Externí odkaz:
https://doaj.org/article/e5e8942457064ba994af859c5a96a398
Publikováno v:
Frontiers in Nutrition, Vol 9 (2022)
Despite continuous advances in pharmacotherapy, atherosclerotic cardiovascular disease remains the world's leading killer. Atherosclerosis relates not only to an increased level of cholesterol, but involves the development of atherosclerotic plaques,
Externí odkaz:
https://doaj.org/article/3a4ec6bc94084db6a2aa7c9a3353cd0f
Publikováno v:
BMC Medicine, Vol 18, Iss 1, Pp 1-6 (2020)
Abstract Background Low-density lipoprotein cholesterol (LDL-C) causes atherosclerotic disease, as demonstrated in experimental and epidemiological cohorts, randomised controlled trials, and Mendelian randomisation studies. Main text There is conside
Externí odkaz:
https://doaj.org/article/8c42f361cd894c3fa6f762e0ba6a6838